Medicxi Ventures Management (Jersey) Ltd 13F holdings
Medicxi Ventures Management (Jersey) Ltd reported 3 positions with a total reported value of $177.4M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-04. Top holdings by reported value: PHAT PHATHOM PHARMACEUTICALS INC (45.6%), NAMS NEWAMSTERDAM PHARMA COMPANY (42.2%), AURA AURA BIOSCIENCES INC (12.2%). Against 2026-03-31 it opened 0 new positions and exited 1. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Medicxi Ventures Management (Jersey) Ltd files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
3 largest of 3 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| PHAT PHATHOM PHARMACEUTICALS INC | 7,464,572 | $81.0M | 45.6% |
| NAMS NEWAMSTERDAM PHARMA COMPANY | 2,208,639 | $74.9M | 42.2% |
| AURA AURA BIOSCIENCES INC | 3,039,892 | $21.6M | 12.2% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30
No new positions.
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 1 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | 19,963,157 | $792.9M | 80.8% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| NAMS NEWAMSTERDAM PHARMA COMPANY | 2,674,182 | 2,208,639 | -17.4% | $74.9M |
CIK 1715579 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
